The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
flosequinan he yi la pu li zhi liao man xing xin shuai de shuang mang bi jiao
Author(s): 
Pages: 246-247
Year: Issue:  4
Journal: World Clinical Drugs

Keyword:  Flosequinan慢性心衰普利充血性心衰心衰病人血管扩张剂单盲扩张作用心功能平行试验;
Abstract: <正> 氟司喹南(Flosequian)是一种新的血管扩张剂,对动脉和静脉均有扩张作用。本文采用随机、双盲、平行试验比较了本品与依拉普利对慢性稳定型心衰病人的疗效和安全性。研究对象来自3个中心的61例中度充血性心衰病人(NYHAⅢ级)。所有病人在单盲安慰剂期后,随机分为氟司喹南组(29例)和依拉普利组(32例)。给药第一周时,本品和依拉普利的剂量分别为75mg和5mg每日1次,给药第二周时分别增至100mg和10mg每日1次,给药第三、四周时剂量再增
Related Articles
No related articles found